Brain Structure and Clinical Endpoints in Myotonic Dystrophy Type 2 — Stella

Clinical trial discovery in plain English. Data sourced from ClinicalTrials.gov.

About Browse conditions ClinicalTrials.gov ↗

Stella is not a medical provider and does not give medical advice. AI-generated summaries are for informational purposes only. Always consult your doctor before making any healthcare decisions.

Brain Structure and Clinical Endpoints in Myotonic Dystrophy Type 2 — Stella

Recruiting

Back to Myotonic Dystrophy Type 2 trials

Trial locations(1 site)

United States

Wake Forest University Health Sciences, Winston-Salem, North Carolina

Key details

Sponsor

Wake Forest University Health Sciences

Collaborators

National Institute of Neurological Disorders and Stroke (NINDS)

Enrollment target

~100 participants

Started

April 2023

Primary completion

June 2027

Age range

30 Years – 65 Years

Last updated February 2026

Interested in joining?

Tell us you're interested and we'll help connect you with the research team. We'll never share your email without your permission.

Your name

Email address

Stella acts as an intermediary. Researcher contact info is never exposed.

Follow this trial

Get notified in plain English when this trial's status changes. No account required.

View full record on ClinicalTrials.gov